Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study

Current guidelines suggest treatment with corticosteroids (CS) in IgA nephropathy (IgAN) when proteinuria is persistently ≥1 g/d despite 3–6 months of supportive care and when eGFR is >50 ml/min per 1.73 m(2). Whether the benefits of this treatment extend to patients with an eGFR≤50 ml/min per 1....

詳細記述

保存先:
書誌詳細
出版年:J Am Soc Nephrol
主要な著者: Tesar, Vladimir, Troyanov, Stéphan, Bellur, Shubha, Verhave, Jacobien C., Cook, H. Terence, Feehally, John, Roberts, Ian S.D., Cattran, Daniel, Coppo, Rosanna
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Nephrology 2015
主題:
Clinical Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4552116/
https://ncbi.nlm.nih.gov/pubmed/25677392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2014070697
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料